Changeflow GovPing Healthcare & Life Sciences Methods and Systems for Long-Range Methylation ...
Routine Notice Added Final

Methods and Systems for Long-Range Methylation Profiling

Favicon for changeflow.com USPTO Patent Applications - Biotech (C12N)
Published
Detected
Email

Summary

Moonwalk Biosciences, Inc. has filed patent application US20260110025A1, published April 23, 2026, covering methods and systems for determining epigenetic profiles of cells in a cell population. The technology involves sequencing DNA molecules to provide sequence reads with methylation status, assembling contigs from overlapping sequence reads, and identifying contigs with different methylation profiles associated with different cells. The application was filed December 29, 2023, under Application No. 19144874. Biotech and pharmaceutical companies developing single-cell epigenomics tools or precision medicine diagnostics may want to review this filing for potential freedom-to-operate considerations.

“Methods for determining an epigenetic profile of a cell in a cell population are described herein.”

USPTO , verbatim from source
Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Applications - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 264 changes logged to date.

What changed

Moonwalk Biosciences, Inc. filed Application US20260110025A1 on December 29, 2023, which was published on April 23, 2026. The application discloses methods for determining epigenetic profiles by sequencing DNA molecules to obtain methylation status across multiple bases, then assembling contigs from overlapping sequence reads. The technology distinguishes cells within a population based on methylation profile differences in contigs with substantially identical nucleobase sequences.

Affected parties include biotech companies developing single-cell sequencing or epigenomics platforms, diagnostic developers using methylation profiling for cancer or developmental biology applications, and research institutions conducting cell population analysis. Parties should review for potential licensing needs or freedom-to-operate concerns, particularly where methylation profiling methods overlap with existing patent portfolios in the epigenomics space.

Archived snapshot

Apr 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

METHODS AND SYSTEMS FOR LONG-RANGE METHYLATION PROFILING

Application US20260110025A1 Kind: A1 Apr 23, 2026

Assignee

Moonwalk Biosciences, Inc.

Inventors

Arash JAMSHIDI, Justin K. VALLEY

Abstract

Methods for determining an epigenetic profile of a cell in a cell population are described herein. The method can include sequencing DNA molecules obtained from cells in a. cell population to provide a plurality of sequence reads comprising a methylation status for a plurality of bases in each sequence read; and assembling a plurality of contigs based on the plurality of sequence reads. Sequence reads having the same nucleobase sequence and methylation statuses within overlapping portions are joined together to form the same contig. Contigs having substantially the same nucleobase sequence and different methylation profiles are identified as being associated with different cells in the cell population.

CPC Classifications

C12Q 1/6869 C12N 9/226 C12N 15/11 C12N 15/907 C12N 2310/20

Filing Date

2023-12-29

Application No.

19144874

View original document →

Get daily alerts for USPTO Patent Applications - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 23rd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Manufacturers Healthcare providers
Industry sector
3254.1 Biotechnology
Activity scope
Patent filing DNA sequencing Epigenomics research
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Medical Devices

Get alerts for this source

We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!